ClinicalTrials.gov
public full text
Public Domain
A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea
The purpose of this study is to estimate the proportion of all adverse events (AEs) including serious adverse events (SAEs) occurring with the use of brigatinib among adult participants who have been administered brigatinib as per the approved indications.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer#888830
- Study Investigating Rapamune For Post-Marketing Surveillance#1124988
- A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants#838132
- Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study#993881
- Korea Comirnaty Post-marketing Surveillance#1126077
Record · ID 1363541
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive